The Rationale for Using HMG-CoA Reductase Inhibitors ('Statins') in Peripheral Arterial Disease

European Journal of Vascular and Endovascular Surgery

Volumn 33, Issue 2, 2007, Pages 192-201

  Erez, G ^a   Leitersdorf, E ^a  

^a Prevention and Treatment of Atherosclerosis   (Israel)

Author keywords

Cerebrovascular disease; Peripheral arterial disease; Primary prevention; Statins

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; COLESTIPOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NICOTINIC ACID; PLACEBO; PRAVASTATIN; PROBUCOL; SIMVASTATIN;

ARTERY DISEASE; ATHEROSCLEROSIS; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; CORONARY ARTERY ATHEROSCLEROSIS; DEVELOPED COUNTRY; DRUG EFFICACY; DRUG MECHANISM; DRUG USE; ENDOVASCULAR SURGERY; HUMAN; META ANALYSIS; MORBIDITY; MORTALITY; PLEIOTROPY; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; VASCULAR SURGERY;

HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MORBIDITY; PERIPHERAL VASCULAR DISEASES; TREATMENT OUTCOME;

EID: 33846221540     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2006.11.020     Document Type: Review

References (44)

1. Iso H., Jacobs Jr. D.R., Wentworth D., Neaton J.D., and Cohen J.D. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. N Engl J Med 320 (1989) 904-910
2. Lindenstrom E., Boysen G., and Nyboe J. Influence of total cholesterol, high density lipoprotein cholesterol and triglycerides on risk of cerebrovascular disease: the Copenhagen city heart study. BMJ 309 (1994) 11-15
3. Prospective studies collaboration. Cholesterol, diastolic blood pressure and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Lancet 346 (1995) 1647-1653
4. Amarenco P., Labreuche J., Lavallée P., and Touboul P.J. Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis. Stroke 35 (2004) 2902-2909
5. SPARCL Investigators. High dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 355 (2006) 549-559
6. Kent D.M. Stroke - an equal opportunity for the initiation of statin therapy. N Engl J Med 355 (2006) 613-615
7. Feringa H.H.H., van Waning V.H., Bax J.J., Elhendy A., Boersma E., Schouten O., et al. Cardioprotective medication is associated with improved survival in patients with peripheral arterial disease. J Am Coll Cardiol 47 6 (2006) 1182-1187
8. Murabito J.M., Evans J.C., Nieto K., Larson M.G., Levy D., and Wilson W.F. Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study. Am Heart J 143 (2002) 961-965
9. National Cholesterol Education Program, Third report of the expert panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) - final report, NIH pub. No. 02-5215, September 2002.
10. Hirsch A.T., Haskal Z.J., Hertzer N.R., Bakal C.W., Creager M.A., Halperin J.L., et al. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic). Circulation 113 (2006) 463-654
11. Schillinger M., Exner M., Mlekusch W., Amighi J., Sabeti S., Muellner M., et al. Statin therapy improves cardiovascular outcome of patients with peripheral artery disease. Eur Heart J 25 (2004) 742-748
12. DeGroot E., Jukema J.W., Montauban van Swijndregt A.D., Zwinderman A.H., Ackerstaff R.G.A., van der Steen A.F.W., et al. B-mode ultrasound assessment of Pravastatin treatment effect on carotid and femoral artery walls and its correlations with coronary arteriographic findings: A report of the Regression Growth Evaluation Statin Study (REGRESS). J Am Coll Cardiol 31 7 (1998) 1561-1567
13. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomized placebo-controlled trial. Lancet 360 (2002) 7-22
14. McDermott M.M., Mehta S., Ahn H., and Greenland P. Atherosclerotic risk factors are less intensively treated in patients with peripheral arterial disease than in patients with coronary artery disease. J Gen Intern Med 12 (1997) 209-215
15. Kinikini D., Sarfati M.R., Mueller M.T., and Kraiss L.W. Meeting AHA/ACC secondary prevention goals in a vascular surgery practice: an opportunity we cannot afford to miss. J Vasc Surg 43 (2006) 781-787
16. Rehring T.F., Sandhoff B.G., Stolcpart R.S., Merenich J.A., and Hollis H.W. Atherosclerotic risk factor control in patients with peripheral arterial disease. J Vasc Surg 41 (2005) 816-822
17. Kroger K. Peripheral arterial procedures and postinterventional prophylaxis. J Endovasc Ther 13 (2006) 32-38
18. Nass C.M., Allen J.K., Jermyn R.M., and Fleisher L.A. Secondary prevention of coronary artery disease in patients undergoing elective surgery for peripheral arterial disease. Vasc Med 6 (2001) 35-41
19. Blankenhorn D.H., Azen S.P., Crawford D.W., Nessim S.A., Sanmarco M.E., Selzer R.H., et al. Effects of Colestipol-Niacin therapy on human femoral atherosclerosis. Circulation 83 (1991) 438-447
20. McDermott M.M., Guralnik J.M., Greenland P., Pearce W.H., Criqui M.H., Liu K., et al. Statin use and leg functioning in patients with and without lower extremity peripheral arterial disease. Circulation 107 (2003) 757-761
21. Giri J., McDermott M.M., Greenland P., Guralnik J.M., Criqui M.H., Liu K, et al. Statin use and functional decline in patients with and without peripheral arterial disease. J Am Coll Cardiol 47 5 (2006) 998-1004
22. Pedersen T.R., Kjekshus J., Pyörälä K., Olsson A.G., Cook T.J., Musliner T.A., et al. Effect of Simvastatin on ischemic signs and symptoms in the Scandinavian Simvastatin Survival Study (4S). Am J Cardiol 81 3 (1998) 333-335
23. Scandinavian Simvastatin Survival Study, Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study. Lancet 344 (1994) 1383-1389
24. Aronow W.S., Nayak D., Woodworth S., and Ahn C. Effect of Simvastatin versus placebo on treadmill exercise time until the onset of intermittent claudication in older patients with peripheral arterial disease at six months and at one year after treatment. Am J Cardiol 92 (2003) 711-712
25. Mondillo S., Ballo P., Barbati R., Guerrini F., Ammaturo T., Agricola E., et al. Effects of Simvastatin on walking performance and symptoms of intermittent claudication in hypercholesterolemic patients with peripheral vascular disease. Am J Med 114 (2003) 359-364
26. Mohler E.R., Hiatt W.R., Creager M.A., and and for the study investigators. Cholesterol reduction with Atorvastatin improves walking distance in patients with peripheral arterial disease. Circulation 108 (2003) 1481-1486
27. Durazzo A.E., Machado F.S., Ikeoka D.T., De Bernoche C., Monachini M.C., Puech-Leao P., et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vasc Surg 39 (2004) 967-975
28. Poldermans D., Bax J.J., Kertai M.D., Krenning B., Westerhout C.M., Schinkel A.F.L., et al. Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation 107 (2003) 1848-1851
29. O'Neill-Callahan K., Katsimaglis G., Tepper M.R., Ryan J., Mosby C., Ioannidis J.P.A., et al. Statins decrease perioperative cardiac complications in patients undergoing non-cardiac vascular surgery: the Statins for Risk Reduction in Surgery (StaRRS) Study. J Am Coll Cardiol 45 (2005) 336-342
30. Parker Ward R., Leeper N.J., Kirkpatrick J.N., Lang R.M., Sorrentino M.J., and Williams K.A. The effect of preoperative statin therapy on cardiovascular outcomes in patients undergoing infrainguinal vascular surgery. Int J Cardiol 104 (2005) 264-268
31. Abbruzzesse T.A., Havens J., Belkin M., Donaldson M.C., Whittemore M.D., Liao J.K., et al. Statin therapy is associated with improved graft patency of autogenous infrainguinal bypass grafts. J Vasc Surg 39 (2004) 1178-1185
32. Baxter B.T. Abdominal aortic aneurysm regression by medical treatment: possibility or pipe dream?. J Vasc Surg 43 (2006) 1068-1069
33. Sukhija R., Aronow W.S., Sandhu R., Kahar P., and Babu S. Mortality and size of abdominal aortic aneurysm at long-term follow-up of patients not treated surgically and treated with and without statins. Am J Cardiol 97 (2006) 279-280
34. Schouten O., van Laanen J.H.H., Boersma E., Vidakovic R., Feringa H.H.H., Dunkelgrün M., et al. Statins are associated with a reduced infrarenal abdominal aortic aneurysm growth. Eur J Vasc Endovasc Surg 32 (2006) 21-26
35. Franklin S.S., Khan S.A., Wong N.D., Larson M.G., and Levy D. Is pulse pressure useful in predicting risk of coronary heart disease?. Circulation 100 (1999) 354-360
36. Oliver J.J., and Webb D.J. Noninvasive assessment of arterial stiffness and risk of atherosclerotic events. Arterioscler Thromb Vasc Biol 23 (2003) 554-566
37. Giannttasio C., Mangoni A.A., Failla M., Stella M.L., Carugo S., Bombelli M., et al. Combined effects of hypertension and hyper-cholesterolemia on radial artery function. Hypertension 29 (1997) 583-586
38. Tomochika Y., Okuda F., Tanaka N., Wasaki Y., Tokisawa I., Aoyagi S., et al. Improvement of atherosclerosis and stiffness of the thoracic descending aorta with cholesterol lowering therapies in familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 16 (1996) 955-962
39. Smilde T.J. The effect of cholesterol lowering on carotid and femoral artery wall stiffness and thickness in patients with familial hypercholesterolemia. Eur J Clin Invest 30 (2000) 473-480
40. Leibovitz E., Hazanov N., Zimlichman R., Shargorodsky M., and Gavish D. Treatment with atorvastatin improves small artery compliance in patients with severe hypercholesterolemia. Am J Hypertens 14 (2001) 1096-1098
41. Shige H., Dart A., and Nestel P. Simvastatin improves arterial compliance in the lower limb but not in the aorta. Atherosclerosis 155 (2001) 245-250
42. Giannattasio C., Mangoni A.A., Failla M., Carugo S., Stella M.L., Stefanoni P, et al. Impaired radial artery compliance in normotensive subjects with familial hypercholesterolemia. Atherosclerosis 124 (1996) 249-260
43. Ferrier K.E., Muhlmann M.H., Baguet J.P., Cameron J.D., Jennings G.L., Dart A.M., et al. Intensive cholesterol reduction lowers blood pressure and large artery stiffness in isolated systolic hypertension. J Am Coll Cardiol 39 (2002) 1020-1025
44. Liao J.K. Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition beyond low density lipoprotein cholesterol. Am J Cardiol 96 Suppl (2005) 24F-33F